• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间运营放射肿瘤科室:意大利的经验

Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.

作者信息

Krengli Marco, Ferrara Eleonora, Mastroleo Federico, Brambilla Marco, Ricardi Umberto

机构信息

Department of Radiation Oncology, University Hospital "Maggiore della Carità," Novara, Italy.

Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

出版信息

Adv Radiat Oncol. 2020 Oct 29;5(Suppl 1):3-6. doi: 10.1016/j.adro.2020.10.002. eCollection 2020 Nov.

DOI:10.1016/j.adro.2020.10.002
PMID:33145459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7598890/
Abstract

Starting from Wuhan, China, SARS-CoV-2 has been a catastrophic epidemic involving many countries worldwide. After China, Italy has been heavily affected, and severe measures to limit the spread of the virus have been taken in the last weeks. Radiation oncology departments must guarantee optimal cancer treatments even in such a challenging scenario of an ongoing aggressive epidemic. Adopted preventive measures and recommendations are highlighted for patients, professionals, and clinical operations to minimize the risk of infection while safely treating patients with cancer.

摘要

自中国武汉开始,新型冠状病毒2(SARS-CoV-2)引发的疫情已在全球多个国家造成灾难性影响。继中国之后,意大利受到严重冲击,在过去几周采取了严格措施以限制病毒传播。即便在当前这种极具挑战性的凶猛疫情形势下,放射肿瘤学部门仍必须确保提供最佳的癌症治疗。本文着重介绍了针对患者、专业人员和临床操作所采取的预防措施及建议,以便在安全治疗癌症患者的同时,将感染风险降至最低。

相似文献

1
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.新冠疫情期间运营放射肿瘤科室:意大利的经验
Adv Radiat Oncol. 2020 Oct 29;5(Suppl 1):3-6. doi: 10.1016/j.adro.2020.10.002. eCollection 2020 Nov.
2
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.新冠疫情期间运营放射肿瘤学科室:意大利的经验
Adv Radiat Oncol. 2020 Mar 20;5(4):527-530. doi: 10.1016/j.adro.2020.03.003. eCollection 2020 Jul-Aug.
3
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures.严重急性呼吸综合征冠状病毒2在布雷西亚市立医院综合医疗网络肿瘤内科医护人员中的传播:预防措施的效果
Front Oncol. 2020 Aug 18;10:1574. doi: 10.3389/fonc.2020.01574. eCollection 2020.
4
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.新型冠状病毒肺炎疫情下胸部肿瘤学面临的挑战与对策
Transl Lung Cancer Res. 2020 Apr;9(2):337-347. doi: 10.21037/tlcr.2020.02.10.
5
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example.早期预防措施在避免新冠病毒传播中的重要性:以沙特阿拉伯为例。
Saudi Pharm J. 2020 Jul;28(7):898-902. doi: 10.1016/j.jsps.2020.05.005. Epub 2020 May 22.
6
COVID-19 Outbreak in Malaysia.马来西亚的新冠疫情爆发。
Osong Public Health Res Perspect. 2020 Jun;11(3):93-100. doi: 10.24171/j.phrp.2020.11.3.08.
7
A comparison of COVID-19, SARS and MERS.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的比较。
PeerJ. 2020 Aug 19;8:e9725. doi: 10.7717/peerj.9725. eCollection 2020.
8
COVID-19 in Italy: Dataset of the Italian Civil Protection Department.意大利的新冠疫情:意大利民防部门数据集
Data Brief. 2020 Apr 10;30:105526. doi: 10.1016/j.dib.2020.105526. eCollection 2020 Jun.
9
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.更好地保护肺癌患者免受COVID-19感染的多级防控措施结果:IEO模型
Front Oncol. 2020 Apr 22;10:665. doi: 10.3389/fonc.2020.00665. eCollection 2020.
10
Global Psychological Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19). What Can Be Learned From Italy. Reflections, Perspectives, Opportunities.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和2019冠状病毒病(COVID-19)的全球心理影响。从意大利能学到什么。思考、观点与机遇。
Front Psychol. 2020 Jul 24;11:1836. doi: 10.3389/fpsyg.2020.01836. eCollection 2020.

引用本文的文献

1
Smile In Totems in Radiotherapy: Patients' Satisfaction with Limited Equipment and COVID-19.放射治疗中的图腾微笑:患者对有限设备及新冠疫情的满意度
Healthcare (Basel). 2022 Aug 13;10(8):1533. doi: 10.3390/healthcare10081533.
2
Radiation Oncology in a Humanitarian Emergency: Experience with Ukrainian Refugees at 2 Cancer Centers in Poland and Italy.人道主义紧急情况下的放射肿瘤学:波兰和意大利两家癌症中心对乌克兰难民的救治经验
Adv Radiat Oncol. 2022 Mar 28;7(4):100956. doi: 10.1016/j.adro.2022.100956. eCollection 2022 Jul-Aug.
3
Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19.癌症患者从 COVID-19 中康复后持久的追踪抗 SARS-CoV-2 抗体。
Sci Rep. 2021 Aug 30;11(1):17381. doi: 10.1038/s41598-021-96195-w.
4
Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic.COVID-19 大流行期间的全球肝细胞癌管理。
World J Gastroenterol. 2021 Jul 7;27(25):3780-3789. doi: 10.3748/wjg.v27.i25.3780.
5
The Top 10 Downloads of 2020 in ASTRO's .美国放射肿瘤学会(ASTRO)2020年十大下载量内容 。
Adv Radiat Oncol. 2021 Jun 17;6(3):100678. doi: 10.1016/j.adro.2021.100678. eCollection 2021 May-Jun.
6
Impact of the COVID-19 Pandemic on Radiotherapy Supply.2019年冠状病毒病疫情对放射治疗供应的影响
Radiol Res Pract. 2021 May 5;2021:5550536. doi: 10.1155/2021/5550536. eCollection 2021.
7
Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience.2019年冠状病毒病大流行期间接受放疗的癌症患者的满意度:一项机构经验
Curr Oncol. 2021 Apr 10;28(2):1507-1517. doi: 10.3390/curroncol28020142.
8
Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing.澳大利亚维多利亚州在应对 COVID-19 第一波和第二波疫情时的放射治疗反应:策略和人员配备。
J Med Imaging Radiat Oncol. 2021 Jun;65(3):374-383. doi: 10.1111/1754-9485.13186. Epub 2021 Apr 27.

本文引用的文献

1
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎(SARS-CoV-2)感染的癌症患者:一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
2
Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients.肿瘤患者流感感染的流行病学、诊断、治疗和预防。
J Oncol Pract. 2019 Apr;15(4):177-184. doi: 10.1200/JOP.18.00567.